Hannah is an MD/PhD student at the University of Arizona-Tucson who joined the program in 2020. In 2018, she graduated from the University of Florida with a Bachelor of Science in Microbiology and Cell Science with a minor in Bioinformatics. After graduation, Hannah dedicated 2 years at the National Institutes of Health (NIH)-NIDA branch to research novel therapeutic treatments for opioid addiction in a behavioral animal model. She completed her PhD in Medical Pharmacology in 2024.